Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) - ETF Exposure

Current share price for FPH : $35.910 0.47 (1.29%)⁺

Fisher & Paykel Healthcare is a designer, manufacturer and marketer of products and systems for use in respiratory care, surgery and the treatment of obstructive sleep apnea. The company products are sold in over 120 countries.

FPH General Information ⁺

ASX Code	FPH
Website	http://www.fphcare.com
Industry/Sector	Health Care Equipment
Market Cap ($M)	21,123
FPH Share Price	$35.910
Day High	$36.380
Day Low	$35.870
Last Close	$36.380
FPH Share Price Movement	$0.47 ( 1.29% )

Prices as at 11:50, 7 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to FPH

As one of Australia's largest companies by market capitalisation, FPH is held across 13 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when FPH moves, funds like FAIR, AQLT, EX20, TCAP and GEAR that hold it can move with it.

For more concentrated exposure, ETFs such as FAIR (BetaShares Australian Sustainability Leaders ETF) allocate about 1.3% to FPH , while the average exposure across all 13 ETFs that hold it is around 0.4% .

Top ETF holdings

BetaShares Australian Sustainability Leaders ETF (FAIR) ~ 1.3%
BetaShares Australian Quality ETF (AQLT) ~ 1.1%
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20) ~ 0.6%
Ten Cap Alpha Plus Complex ETF (TCAP) ~ 0.6%
Betashares Geared Australian Equity Fund (GEAR) ~ 0.5%

Last updated: ETF data and holdings as at 6 September 2026

Own FPH directly or through an ETF?

How does holding Fisher & Paykel Healthcare Corporation Limited (FPH) shares directly compare to ETFs that include it?

	FPH Direct	FAIR ASX	AQLT ASX	EX20 ASX	TCAP ASX	GEAR ASX
Holdings	1 company	83 holdings	46 holdings	193 holdings	105 holdings	212 holdings
FPH Weight	100%	1.3%	1.1%	0.6%	0.6%	0.5%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.49% p.a.	0.35% p.a.	0.2% p.a.	0.97% p.a.	2.11% p.a.
Approx. Yield	1.6%	3.06%	4.07%	2.72%	2.68%	1.73%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not FPH's direct yield. Annual cost uses each ETF's MER.

FPH Exposure on $10,000 investment

How a $10,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Fisher & Paykel Healthcare Corporation Limited (FPH)	Direct share	$35.910	-1.43%	-$143	$9,857
BetaShares Australian Sustainability Leaders ETF (FAIR)	Equity - Australia Strategy	$18.900	-0.53%	-$53	$9,947
BetaShares Australian Quality ETF (AQLT)	Equity - Australia Strategy	$35.390	-0.48%	-$48	$9,952
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20)	Equity - Australia Small/Mid Cap	$23.000	-1.37%	-$137	$9,863
Ten Cap Alpha Plus Complex ETF (TCAP)	Equity - Australia Strategy	$9.700	-1.52%	-$152	$9,848
Betashares Geared Australian Equity Fund (GEAR)	Equity - Australia Strategy	$37.660	-0.76%	-$76	$9,924

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Fisher & Paykel Healthcare Corporation Limited (FPH) ETFs

13 ETFs hold Fisher & Paykel Healthcare Corporation Limited (FPH).

ETF	FPH Weight	MER	Yield
BetaShares Australian Sustainability Leaders ETF (FAIR)	1.3%	0.49%	3.06%
BetaShares Australian Quality ETF (AQLT)	1.1%	0.35%	4.07%
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20)	0.6%	0.2%	2.72%
Ten Cap Alpha Plus Complex ETF (TCAP)	0.6%	0.97%	2.68%
Betashares Geared Australian Equity Fund (GEAR)	0.5%	2.11%	1.73%
Betashares Australian Dividend Harvester Fund (HVST)	0.5%	0.72%	5.53%
BetaShares Australia 200 ETF (A200)	0.2%	0.04%	3.2%
Betashares Managed Risk Australian Share Fund (AUST)	0.2%	0.49%	2.96%
Betashares Global Cash Flow Kings ETF (CFLO)	0.1%	0.4%	3.06%
Betashares Global Shares ETF (BGBL)	0%	0.08%	1.17%

View all 13 ETFs

Fisher & Paykel Healthcare Corporation Limited (FPH) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	27.01¢	0%	22 Jun 2026	3 Jul 2026	-	-	-
Result	16.52¢	0%	3 Dec 2025	16 Dec 2025	-	-	-
HFResult	22.26¢	0%	23 Jun 2025	4 Jul 2025	-	-	-

See all dividends from Fisher & Paykel Healthcare Corporation Limited (FPH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Fisher & Paykel Healthcare Corporation Limited (FPH) price-sensitive announcements

FPH - Profit Guidance

Fisher & Paykel Healthcare Corporation Limited has provided guidance for the first half an

Fisher & Paykel Healthcare Corporation Limited (FPH)
21 Aug 2026 | 7:30 AM

FPH - Preliminary Final Report

Fisher & Paykel Healthcare Corporation Limited reported strong financial performance for t

Fisher & Paykel Healthcare Corporation Limited (FPH)
26 May 2026 | 7:30 AM

FPH - Profit Guidance

Fisher & Paykel Healthcare Corporation Limited updated its financial year 2026 revenue and

Fisher & Paykel Healthcare Corporation Limited (FPH)
23 Feb 2026 | 7:30 AM

FPH - Half Yearly Report and Accounts

Fisher & Paykel Healthcare Corporation Limited reported a strong financial performance in

Fisher & Paykel Healthcare Corporation Limited (FPH)
26 Nov 2025 | 7:30 AM

Fisher & Paykel Healthcare Corporation Limited (FPH) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	Ongoing Disclosure Notices - Options	3 Sep 2026 1:22PM	$36.380	$35.910	fallen by 1.29%
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	Notification of cessation of securities - FPH	2 Sep 2026 1:12PM	$36.150	$35.910	fallen by 0.66%
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	Options Update	2 Sep 2026 1:12PM	$36.150	$35.910	fallen by 0.66%
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	Application for quotation of securities - FPH	31 Aug 2026 11:14AM	$36.685	$35.910	fallen by 2.11%
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	2026 Annual Shareholders Meeting Results	25 Aug 2026 2:29PM	$37.520	$35.910	fallen by 4.29%
Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX	Health Care	$21,124	2026 Annual Shareholders Meeting Speeches and Presentation	25 Aug 2026 7:32AM	$37.090	$35.910	fallen by 3.18%

FPH Financial Summary

Year to Mar	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026F	$369.56	$62.68	20.50%	50.40	46.74	1.48%	0.0%
2025F	$306.71	$52.02	24.40%	60.73	39.37	1.25%	0.0%
2024A	$245.09	$41.82	-0.30%	52.86	38.47	1.74%	0.0%

FPH Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F
Cochlear Limited (COH)	$9,219M	-0.3136	0.2540	0.0785	34.3201	27.3686	25.3767	2.45%	2.54%	2.77%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$21,312M	0.1388	0.1617	0.1748	54.7860	47.1622	40.1440	1.20%	1.29%	1.46%
ResMed Inc. (RMD)	$18,976M	9.5922	0.0984	0.0886	20.8363	18.9691	17.4251	1.12%	1.21%	1.31%

FPH Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	1.60	51.40	12.10	3.07
Market	0.63	16.60	1.71	1.29
Sector	0.63	20.10	2.04	2.52

FPH Directors

Name	Position	Start Date
Mr Lewis George Gradon	Chief Executive Officer, Managing Director	1 Apr 2016
Mr George Roger Wayne France	Non-Executive Director	24 Feb 2009
Sir Colin James Maiden	Non-Executive Director	5 May 1992
Mr W Lindsay Gillanders	Non-Executive Director	1 May 1992
Sir Michael Grenfell Daniell	Non-Executive Director	16 Nov 2001
Dr Nigel T Evans	Non-Executive Director	16 Nov 2001
Dr Lisa Margaret McIntyre	Non-Executive Director	1 Oct 2021
Mr Andrew Mark Cross	Non-Executive Director	1 Oct 2024
Mr Graham McLean	Non-Executive Director	1 Oct 2023
Dr Cather Simpson	Non-Executive Director	1 Jun 2022
Ms Anna Curzon	Non-Executive Director	1 Feb 2026
Mr Neville Mitchell	Non-Executive Director, Non-Executive Chairman	12 Nov 2018

Fisher & Paykel Healthcare Corporation Limited (FPH) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
17 Feb 2025	MCLEAN, Graham	Buy	Indirect Shares	1,000	$32.300	$32,300.000
12 Sep 2024	MCLEAN, Graham	Buy	Indirect Shares	800	$34.915	$27,932.000
21 Sep 2022	O'DWYER, Donal	Buy	Indirect Shares	3,000	$19.261	$57,782.000

See all changes in directors' interest & trades for Fisher & Paykel Healthcare Corporation Limited (FPH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

FPH Management

Name	Position
Lyndal York	Chief Financial Officer
Andy Niccol	Chief Operating Officer
Raelene Leonard	Company Secretary
Desh Edirisuriya	General Manager - New Zealand Operations
Marcus Driller	Vice President - Corporate
Nicola Talbot	Vice President - Human Resources
Nicholas Fourie	Vice President - Information & Communication Technology
Jonti Rhodes	Vice President - Network Design, Facilities, Infrastructure & Sustainability
Andrew Somervell	Vice President - Products & Technology
Brian Schultz	Vice President - Quality, Safety & Regulatory Affairs
Justin Callahan	Vice President - Sales & Marketing
Winston Fong	Vice President - Surgical Technologies

FPH Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Fisher & Paykel Healthcare Corporation Limited (FPH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
44,727,643 (7.62%)	BlackRock, Inc. and related bodies corporate
41,537,167 (7.07%)	Australiansuper Pty Ltd

FPH Calendar of Events

Date	Event
25 May 2027	Report (Prelim)
25 November 2026	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us